GOSSELIES, BELGIUM

CELL THERAPY FACILITIES

Our European Center of Excellence in cell therapy at Gosselies, Belgium includes a 25,830 sq. ft. Clinical Manufacturing facility and a 41,000 sq. ft. purpose-built CGxP facility offering advanced clinical and commercial supply. An additional large-scale 60,000 sq. ft. commercial dedicated plant is currently under construction and expected to be fully commissioned in 2022.

Our state-of-the-art facilities are FDA/EU fitted offering autologous and allogeneic platforms from process development to clinical and commercial cell therapy manufacturing. The facilities offer4 process development labs, 12 agility by design cleanrooms for EU and US CGMP manufacturing, grade B storage, nitrogen storage, fill/finish services, quality control labs, warehousing, and storage space.

Size: 130,000+ ft²

GOSSELIES, BELGIUM SITE TOUR VIDEO

PLASMID DNA FACILITY

Our Gosselies campus also includes a 17,000 sq. ft. plasmid DNA development and manufacturing facility that includes R&D, process development and QC laboratories and multiple GMP production suites.

Size: 17,000 ft²

CELL THERAPY CAPABILITIES

• Process Development/Industrialization
• EU and US CGMP Clinical and Commercial Manufacturing
• Analytical Services
• Fill/Finish

FEATURED TECHNOLOGIES

• Plasmid DNA
• Chimeric Antigen Receptor (CAR)-T
• T Cell Receptors (TCR) and Tumor Infiltrating Lymphocytes (TIL)
• Mesenchymal Stem Cells (MSCs)
• Natural Killer Cells (NKs)

ACCREDITATIONS

• ANVISA Approved
• Australia
• Belarus
• Canada
• EMA Approved
• FDA Approved
• Japan
• South Korea
• Turkey
• Taiwan

SALES INQUIRIES

Reach out to one of our experts to discuss any of our offerings or a specific solution for your project challenges.

CAREERS

We recognize talent is our most important asset. To explore a career with Catalent, visit our Careers Section to submit your resume.